Dr. Jonathan K. Wilkin, MD, FAAD, joins Patagonia's Advisory Board
Patagonia Pharmaceuticals is delighted to announce that Dr. Jonathan K. Wilkin, MD, FAAD, has joined Patagonia's growing Advisory Board. Dr. Wilkin is the founding Director (retired) of the Division of Dermatology and Dental Products at the US Food and Drug Administration. Before going to the FDA, he was Director of Dermatology at the Ohio State University and Professor of Pharmacology and Medicine. He has over 130 publications in dermatology and clinical pharmacology. Dr. Wilkin has served as chairman of the medical advisory board for the National Rosacea Society from 1998 to 2012 as well as having chaired their Expert Committees on the Classification and Staging System for Rosacea. He also has served on the American Academy of Dermatology’s (AAD) Ad Hoc Task Force on the Academy’s Efforts with FDA and on their Environment and Drugs Committee. Dr. Wilkin has been active in the American Society for Clinical Pharmacology and Therapeutics, having chaired the Dermatologic and Allergic Diseases Section and the Constitution and By-laws Committee for several years, as well as serving in other capacities. Dr. Wilkin is a fellow of the AAD, a member of the American Dermatological Association and board certified by both the American Board of Dermatology and the American Board of Clinical Pharmacology.
Patagonia is thrilled to welcome Dr. Wilkin to the team!